MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
6849.T stock logo

6849.T

Nihon Kohden Corporation

$1442.5
-2
 (-0.14%)
[ms_data_label text=’Delayed data’]
Exchange:  JPX
Market Cap:  234.248B
Shares Outstanding:  170.33M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Devices
   
CEO:  Hirokazu Ogino
Full Time Employees:  5891
Address: 
1-31-4 Nishiochiai
Tokyo
161-8560
JP
Website:  https://www.nihonkohden.com
Nihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company offers physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring instruments, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. It also provides patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables, such as electrodes and sensors. In addition, the company offers treatment equipment, which include defibrillators, automated external defibrillators (AED), ventilators, pacemakers, anesthesia machines, cochlear implants, and related consumables and services, which include AED pads and batteries; and other medical equipment, including hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Additionally, it engages in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Tokyo, Japan.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue206,603,000221,986,000225,424,000
Gross Profit103,265,000108,568,000114,298,000
EBITDA24,912,00023,445,00024,904,000
Operating Income21,121,00019,592,00020,714,000
Net Income17,110,00017,026,00014,098,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets216,728,000233,233,000258,276,000
Total Liabilities49,121,00052,148,00076,980,000
Total Stockholders Equity167,604,000181,082,000179,552,000
Total Debt441,000654,00026,076,000
Cash and Cash Equivalents33,459,00036,132,00028,428,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow-2,513,00015,607,00015,286,000
Capital Expenditure-7,458,000-3,626,000-7,126,000
Free Cash Flow-9,971,00011,981,0008,160,000
Net Income17,110,00017,026,00014,098,000
Net Change in Cash-16,108,0005,890,000-6,816,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)237,107,417.783Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)264,991,811.060Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)248,120,000Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)31,449,231.421Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)35,147,735.438Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)32,909,907.978Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)18,188,052.046Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)21,007,989.508Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)19,301,749.716Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)85,194,992.218Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)95,214,124.856Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)89,151,919.694Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)116.200Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)126.470Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)109.500Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)3Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)2Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
1.08
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
20.25
?Enterprise Value
 (TTM)
: 
231.308B  ?EV/FCF
 (TTM)
: 
17.55
?Dividend Yield
 (TTM)
: 
0.02  ?Payout Ratio
 (TTM)
: 
0.42
?ROE
 (TTM)
: 
0.07  ?ROIC
 (TTM)
: 
0.06
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
0.15
?P/B
 (TTM)
: 
1.45  ?Current Ratio
 (TTM)
: 
3.64

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
2,744.22Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate T Intrinsic Value

Common questions about 6849.T valuation

Is Nihon Kohden Corporation (6849.T) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Nihon Kohden Corporation (6849.T) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is 6849.T a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether 6849.T trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is 6849.T’s P/E ratio?

You can see 6849.T’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for 6849.T?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is 6849.T a good long-term investment?

Whether 6849.T fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

6849.T

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

[ms_data_label text="Daily snapshot"]

-0.14
MARKETSnap

Trading Metrics:

[ms_session_rows_unavailable]
Open: [ms_cell_or_dash table='trading_quote' column='open']   Previous Close: [ms_cell_or_dash table='trading_quote' column='previousClose']
Day Low: [ms_cell_or_dash table='trading_quote' column='dayLow']   Day High: [ms_cell_or_dash table='trading_quote' column='dayHigh']
Year Low: 1415.5   Year High: 1885.5
Price Avg 50: 1540.97   Price Avg 200: 1655.57
Volume: 361800   Average Volume: 634175

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read